focus -WSS

focus

author：knowledge 2025-08-28 08:39:42 - browse：86

Illumina building. -- biotech coverage from STAT — Adobe

LONDON — The European Union on Wednesday issued an antitrust fine of $475 million to the U.S. genetic sequencing giant Illumina for closing its acquisition of cancer detection company Grail before clearing it with regulators.

The fine amounts to nearly 10% of Illumina’s annual global revenue, which is the most the European Commission can penalize a company under its merger regulations. The commission called Illumina’s actions “an unprecedented and very serious infringement” of the EU’s policies, including the “cornerstone” that regulators review deals that can alter the market.

The commission also issued what it called a symbolic fine of 1,000 Euros, or about $1,100, to Grail for what it said was the firm’s “active role” in the deal’s infringement of EU rules.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Beware reading your test results before your doctor does

knowledge

focus

WSS

'Screen and refer' systems are hurting patients

A letter from the executive editor: The 2023 STATUS List

In 'major milestone,' FDA approves first cell therapy for solid tumors

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Secretariat’s lessons for human medicine

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Wikipedia

focus

knowledge

Hepatitis C has a cure — but many Americans still lack access to it

Use doctors trained outside the U.S. to ease the physician shortage

23andMe had bad news about my health. I wish a person had delivered it

Lupron, used to halt puberty in children, may cause lasting health problems

Peter Hotez and the public health issue of online harassment

What affirmative action's end means to a medical student

Guidelines to prevent youth baseball injuries need more muscle

Congress may force more Covid

Duchenne breakthrough therapy leaves behind pioneering families

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

focus

Abridge raises $150m as clinical notes automation market heats up

UpToDate has a racism problem: Dr. Stanley Goldfarb

WATCH: Why do our ears pop?

New CMS data security rules will hurt Medicare, Medicaid research

New study raises questions about niacin and heart health

Opioid cravings were reduced by anti

entertainment

knowledge

focus

Wikipedia